Maksym, R. B. (2021). Implementation of ethiodized oil for treatment of endometriosis-associated infertility. Kwartalnik Naukowy Fides et Ratio. https://doi.org/10.34766/fetr.v47i3.897
Maksym RB. Implementation of ethiodized oil for treatment of endometriosis-associated infertility. Kwartalnik Naukowy Fides et Ratio. 2021. doi:10.34766/fetr.v47i3.897
Maksym, Radosław Bernard. "Implementation of ethiodized oil for treatment of endometriosis-associated infertility." Kwartalnik Naukowy Fides et Ratio, 2021.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
RRM Academy Synopsis
Oil contrast tubal flushing raised pregnancy rates in endometriosis
A 2021 narrative review reports more pregnancies in women with endometriosis after the tubes were flushed with ethiodized oil. In the FLUSH randomized trial, about 5 out of 10 women with endometriosis got pregnant after the flush, against about 1 out of 10 without it.
Key Findings
In the FLUSH randomized trial, 48.0% of women with confirmed endometriosis became pregnant after the oil flush, against 10.8% in the control group (RR 4.44, 95% CI 1.61–12.21).
Deliveries among women with endometriosis in FLUSH rose from 10.8% to 40%, with results first assessed in the six months after the procedure.
H2Oil randomized 1,119 infertile patients across 27 hospitals in the Netherlands to oil or water-soluble contrast. No patients with diagnosed endometriosis took part.
At six months in H2Oil, pregnancy followed oil contrast in 39.7% of women and water-soluble contrast in 29.1%. Deliveries followed in 38.8% and 28.1%.
In H2Oil's five-year follow-up, 80% of women given oil contrast became pregnant and 74.8% gave birth, counting pregnancies after other treatments.
Interpretation
The paper is a narrative review by one author. It draws on FLUSH, a randomized trial of a few hundred patients, on the larger H2Oil trial, and on earlier observational reports. FLUSH supplies the endometriosis result. H2Oil enrolled no women with diagnosed endometriosis. The author states that further evaluation is needed to define the procedure's place in care and how the oil acts in tissue.
RRM Context
The review names radical excision as the main treatment for endometriosis in women trying to conceive. Removing the lesions is linked to better immune function. The author notes that many women labeled with unexplained infertility may have hidden endometriosis. Restorative reproductive medicine looks for such causes first.
Our editorial summary of this paper, not the article's abstract.
Abstract
One of the leading health conditions associated with female infertility is endometriosis, which is the presence of endometrial-like tissue outside the uterine cavity. It is estimated that endometriosis can be demonstrated in up to half of infertile patients, but this does not mean that in all cases, it is the only cause that reduces fertility. Apart from the relatively rare case of endometriosis-induced anatomical changes that mechanically impede fertilization, the main effect is to modify the immune system by the secretion of soluble signaling factors by ectopic endometriotic lesions. The primary treatment of endometriosis in patients trying to become pregnant is radical excision of foci outside the uterus, which is associated with the normalization of immune system disorders and often leads to pregnancy. However, the significant technical complexity and the possibility of complications make the surgery a good solution, mainly for patients who, apart from infertility, pain is also an important factor. An important medical problem remains the development of methods that could eliminate disorders caused by endometriosis and, at the same time, could be used in patients with minor or moderate ailments and in patients with contraindications to surgery. At present, despite many approaches, there are no specific immunotherapy methods. It is interesting that for several decades, it has been reported that the examination of the patency of the Fallopian tubes has a beneficial effect on the possibility of pregnancy. Detailed analyzes have shown that this is not a common effect, but it mainly concerns patients with endometriosis and the use of etiodized oil contrast. In this group, there is a significant, five-fold increase in infertility. Therefore, every second previously infertile patient becomes pregnant within six months. A smaller but also distinct effect is observed in the case of idiopathic infertility. The impact is so significant that it can be used both for the practical treatment of patients as well as to understand the mechanisms underlying fertility disorders occurring in endometriosis. The data so far show that the immunotherapeutic effect of etiodized oil contrast is overwhelming. However, it is not entirely clear why the improvement is not achieved using other currently more popular water contrasts. The dissemination of perfusion of the uterine cavity and Fallopian tubes with the use of oil contrast seems to be a simple, safe and effective strategy that allows patients to offer patients alternative treatment methods and improve the final effectiveness and increase the pharmacoeconomics of treatment of endometriosis-related infertility.